Basic info
Industry
biotechnology research
Sectors
Biotechnology
Health Care
Therapeutics
Rare disease and primary immunodeficiencies
Pharmaceutical
Clinical Trials
Date founded
2014
Funding rounds raised
Total raised
$115M
from 16 investors over 16 rounds
X
X4 Pharmaceuticals raised $115M on August 3, 2023
Investors: Hercules Capital, Inc.
X
X4 Pharmaceuticals raised $55M on June 30, 2022
Investors: Hercules Capital, Inc., AXA Investment Managers, Lumira Ventures, Acorn Bioventures and OrbiMed Advisors
X
X4 Pharmaceuticals raised $55M on March 19, 2021
Investors: Lincoln Park Capital, LLC, Ikarian Capital LLC, Abingworth, OrbiMed Advisors, Driehaus Capital Management LLC, Monashee Investment Management LLC, Altium Capital and Sio Capital Management LLC
X
X4 Pharmaceuticals raised undisclosed on November 16, 2017
Investors: Thynk Capital
X
X4 Pharmaceuticals raised undisclosed on January 1, 2014
Investors: SV Life Sciences